Q32 Bio, Inc. (QTTB)
8.23
-0.02
(-0.24%)
USD |
NASDAQ |
Oct 02, 16:00
8.24
+0.01
(+0.12%)
After-Hours: 20:00
Q32 Bio EPS Diluted (Quarterly) : -0.4398 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4398 |
| March 31, 2026 | -0.5398 |
| December 31, 2025 | 4.584 |
| September 30, 2025 | -0.6036 |
| June 30, 2025 | -0.7779 |
| March 31, 2025 | -0.9044 |
| December 31, 2024 | -1.165 |
| September 30, 2024 | -1.457 |
| June 30, 2024 | -1.419 |
| March 31, 2024 | -6.328 |
| December 31, 2023 | -76.40 |
| September 30, 2023 | -40.52 |
| June 30, 2023 | -16.69 |
| March 31, 2023 | -19.84 |
| December 31, 2022 | -10.74 |
| September 30, 2022 | -10.57 |
| June 30, 2022 | -9.124 |
| March 31, 2022 | 28.65 |
| Date | Value |
|---|---|
| December 31, 2021 | -10.58 |
| September 30, 2021 | -9.648 |
| June 30, 2021 | -9.717 |
| March 31, 2021 | -0.3836 |
| December 31, 2020 | -11.15 |
| September 30, 2020 | -11.24 |
| June 30, 2020 | -14.07 |
| March 31, 2020 | -14.08 |
| December 31, 2019 | -9.869 |
| September 30, 2019 | -12.15 |
| June 30, 2019 | -10.98 |
| March 31, 2019 | -11.48 |
| December 31, 2018 | -9.059 |
| September 30, 2018 | -6.832 |
| June 30, 2018 | -6.068 |
| March 31, 2018 | -73.56 |
| December 31, 2017 | -5.725 |
| September 30, 2017 | -3.139 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -0.7989 |
| Beam Therapeutics, Inc. | -1.176 |
| Prime Medicine, Inc. | -0.2376 |
| Prelude Therapeutics, Inc. | -0.1415 |
| Twist Bioscience Corp. | -0.5617 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.946M |
| Total Expenses (Quarterly) | 8.946M |
| Enterprise Value | 94.38M |
| Earnings Yield | 36.47% |
| Operating Earnings Yield | 17.60% |
| Normalized Earnings Yield | 36.53 |